Purpose: The purpose of this study was to evaluate a pharmacist initiated conversion program from intravenous (IV) to oral corticosteroids in patients with chronic obstructive pulmonary disease (COPD) exacerbations.
Methods:We conducted a retrospective observational study of patients who were admitted with a diagnosis of COPD exacerbation. The historical control group, included patients admitted between October 1 and December 31, 2013, did not have any intervention from pharmacists regarding conversion. The post intervention group, included patients admitted between October 1 and December 31, 2014, exposed to the new conversion program. Electronic medical records were reviewed for: time needed for conversion, hospital length of stay, and readmission rate for both groups.Results: There were a total of 122 patients in the study. A low number of patients in the post intervention group (n = 11, 22%) received pharmacist intervention. No significant difference was observed in hospital length of stay, time to conversion, or 30-day readmission rates. More patients in the intervention group received methylprednisolone as initial IV therapy (P = 0.002).
Conclusions:Among patients with COPD exacerbations, the automatic pharmacist medicated conversion program did not affect time to conversion, hospital length of stay, or readmission rates.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.